Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.
about
Vaccination for hepatitis C virus: closing in on an evasive targetRegulating the immune system via IL-15 transpresentationCytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccinesAn anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVImmunogenicity of novel consensus-based DNA vaccines against Chikungunya virusMolecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationSafety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adultsObstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.Chikungunya: a potentially emerging epidemic?A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primatesThe cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineUsing 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.Vaccine-induced myeloid cell population dampens protective immunity to SIVPlasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity modelInnate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesHIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivoT cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.Specific pathogen-free status alters immunophenotype in rhesus macaques: implications for the study of simian immunodeficiency virus.TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques.HIV DNA Vaccine: Stepwise Improvements Make a Difference.Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4(+) T Cells and Antigen Duration.The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responsesImmunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infectionPlasmodium inui infection reduces the efficacy of a simian immunodeficiency virus DNA vaccine in a rhesus macaque model through alteration of the vaccine-induced immune response.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeIL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaquesDNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells.Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251.Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA VaccineConfiguration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor ImmunitySequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge
P2860
Q22305922-C1B82E65-99BE-46B6-AD44-3B9FE52DCE1AQ26825247-A711AE5D-0014-49FC-BA7C-4DBD30A9FD94Q26827712-A3CEE111-D34F-4C3D-BB79-F04D93E38DF7Q27349203-BCB2950D-7511-4C4E-A2F2-2E9FA3250429Q27487330-20C3C5FE-653F-4902-86C5-354863CB2C51Q28236770-9B46385F-6000-4E06-AEC6-00CCB370416AQ28740321-33CB5B53-37A3-4339-B372-6657B45879CBQ30378897-C010083B-921C-42A0-B439-45172589BE04Q30388754-B31A37F1-2988-4EFD-ADCA-80B6204E6E0EQ30398956-4A45B4E8-0BFB-4F8F-A726-F4F81CFAF733Q30406147-077D9868-C36F-41C0-BC66-C22C499D85F5Q33527383-E99E1384-93AE-4352-8B8F-708A673B05C2Q33609436-0A3903B2-BC86-49DB-AE9F-C621E83D4B3BQ33685961-2FE6BA9D-D2CA-42C3-827C-207DCBB89B84Q33690988-4D18109F-32BD-4244-A5EF-13C38D1F9307Q33987553-4A2CF553-B3CD-4CA5-B325-1793BC561635Q34006329-AF1B9E75-4801-455F-886F-41796BF860F0Q34250318-82D0A1F7-7748-4352-B269-6015898D772EQ34305570-ABA6FA9E-0102-4A8C-8C7C-E6C1B00C4AA4Q35046349-5747E88B-0F1D-40AE-B918-2FDC3FE7F76CQ35082880-9FB66285-08AD-4199-9426-03C4780A40C5Q35216404-77D943EC-5BC3-41A8-815C-401FFE4A09D1Q35267854-175B9A40-64C7-4EB4-8D5D-E3370D83BA1AQ35672335-C323E2B7-B542-4001-8E48-E7069547FC19Q35826742-A15E7054-FDCB-4536-8208-F324F9F675F8Q35826774-FD527AD8-2466-4A16-89FC-84457E41E545Q35871793-1207B408-9D9F-470B-BC2D-E2BDF2980B1DQ36102001-A81528B2-1318-4715-BFCD-50CBB07FC05FQ36256348-B408F186-31AA-440B-893A-6A3DCC8482BAQ36256428-716C49DC-C9C9-40BE-A3E6-AB9CB1EE0BFFQ36331205-A208D914-E775-4146-9F30-4118CC7A6DC6Q36379235-7C0C76AB-5592-4992-AA5A-0E2A54DA8A90Q36498186-23BE9049-FDA5-4C15-A0C5-443503DCE497Q36637349-E700B474-B925-4605-8625-63EF9BDD528AQ36694836-C6A3B462-3792-4E29-8E3A-9BAEB0E79C10Q36694851-97E1DBDA-2100-4682-B05A-584A06F29463Q36808324-F8184115-EA27-415C-9B4D-94B4DFC52130Q36837548-0227F9A9-9169-469B-9207-AB961B6F332CQ36884768-A7C29E9B-1ECF-4EE8-AA3B-537A36347A6AQ36949703-0DEEA3A9-8BBF-4BE2-BE6B-C64313075EB1
P2860
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@ast
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@en
type
label
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@ast
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@en
prefLabel
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@ast
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@en
P2093
P2860
P356
P1476
Protection against simian/huma ...... HIV antigen and IL-15 plasmid.
@en
P2093
Barbara K Felber
Charles Brown
David A Hokey
David B Weiner
George N Pavlakis
Gordon Vansant
Jean D Boyer
John Eldridge
Joseph Monforte
P2860
P304
18648-18653
P356
10.1073/PNAS.0709198104
P407
P50
P577
2007-11-13T00:00:00Z